Advertisement
Document › Details
Centogene N.V.. (5/15/24). "Press Release: Centogene Reports Full Year 2023 Financial Results and Recent Business Highlights". Cambridge, MA, Rostock & Berlin.
Organisation | Centogene N.V. (OTCOX: CNTGF) | |
Group | Centogene (Group) | |
Organisation 2 | Lifera (SA) | |
Group | Lifera (Group) | |
Product | Centogene Biodatabank | |
Product 2 | DNA testing services | |
Person | Stratton, Kim (Centogene 202202– CEO before Orphazyme + Shire Pharmaceuticals + Novartis) | |
Person 2 | Coego Rios, Miguel (Centogene 202206– CFO joined as EVP Finance + Legal in 2/22 before Orphazyme + Mundipharma + Shire) | |
Original document
accessed by [iito] on 2024-11-21
Record changed: 2024-12-09 |
Advertisement
More documents for Centogene (Group)
- [1] Centogene N.V.. (11/13/24). "Press Release: Centogene Signs Strategic Transaction with Private Equity Group Charme Capital Partners [not for release, publication or distribution, where unlawful]". Cambridge, MA & Rostock....
- [2] Centogene N.V.. (8/7/24). "Press Release: Centogene Receives Delisting Notice From Nasdaq". Cambridge, MA, Rostock & Berlin....
- [3] Centogene N.V.. (6/20/24). "Press Release: C-Path and Centogene MOU to Enhance Collaboration in Lysosomal Disease Research and Drug Development". Tucson, AZ, Cambridge, MA & Rostock....
- [4] Centogene N.V.. (5/15/24). "Press Release: Centogene Secures Approx. $20 Million to Strengthen Cash Position. Expanding Relationship With Lifera, a Biopharma Company Owned by the PIF". Cambridge, MA, Rostock & Berlin....
- [5] Centogene N.V.. (5/14/24). "Press Release: Centogene and Evotec Discover Promising New Molecule to Treat Gaucher Disease". Cambridge, MA, Rostock & Berlin....
- [6] Centogene N.V.. (2/28/24). "Press Release: Centogene Announces Receipt of Nasdaq Notice of Delisting and Intention to Request a Hearing". Cambridge, MA, Rostock & Berlin....
- [7] Centogene N.V.. (2/28/24). "Press Release: Centogene Explores Strategic Alternatives". Cambridge, MA, Rostock & Berlin....
- [8] Centogene N.V.. (11/28/23). "Press Release: Centogene and Lifera, a Public Investment Fund (PIF) Company, Complete Strategic Joint Venture Transaction". Cambridge, MA, Rostock & Berlin....
- [9] Centogene N.V.. (6/27/23). "Press Release: Centogene and Lifera, a Biopharma Company Owned by the PIF, Enter Strategic Collaboration – Forming Saudi Arabian Joint Venture to Increase Access to Leading Data-Driven Multiomic Testing and Securing CENTOGENE...
- [10] Centogene N.V.. (6/14/23). "Press Release: Centogene Receives Nasdaq Notification Regarding Minimum Market Value of Publicly Held Shares Deficiency". Cambirdge, MA, Rostock & Berlin....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top